Paul Elliot Mann - 30 Jun 2026 Form 3 Insider Report for AETERNUM HEALTH, INC. (AETN)

Reporting relationship
CEO, Director, 10%+ Owner
Issuer ticker
AETN
Reported as of
30 Jun 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
15 Jul 2026, 13:56:36 UTC
Prior SEC filing
03 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Paul Mann

Key filing fact

Paul Elliot Mann filed Form 3 for AETERNUM HEALTH, INC. (AETN) on 15 Jul 2026.

Key facts

  • This page summarizes Paul Elliot Mann's Form 3 filing for AETERNUM HEALTH, INC. (AETN).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 15 Jul 2026, 13:56.

Change

  • Previous filing in this sequence was filed on 03 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001744816 Primary reporting owner

Mann Paul Elliot

Relationship
CEO, Director, 10%+ Owner
Address
601 PENNSYLVANIA AVE., N.W., SUITE 500, WASHINGTON
Signature
/s/ Paul Mann
Signature date
15 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AETN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
49,000,000
Date
30 Jun 2026
Ownership
Direct
Footnotes
F1
AETN holding

Preferred Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,000,000
Date
30 Jun 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares were issued in connection with a reverse merger agreement between Aeternum Health, LLC and Shorepower Technologies, Inc.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .